ArticleBiomedicines2024

The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.

Giuseppe Stefano Netti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.